Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
This study has been terminated.
(negative endpoint study resulting in withdrawal of study drug)
Sponsor:
Ludwig-Maximilians - University of Munich
Information provided by (Responsible Party):
Klaus Parhofer, Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT01239992
First received: November 12, 2010
Last updated: February 12, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |